CLINICAL ROLE -
Lymphoma Biosimilar Potentially Equivalent to Reference Product
Results from an interim analysis show ritixumab biosimilar to be equivalent to reference product.
Read More
What Is the Pharmacist's Role in Explaining Treatment Options for Patients With Cancer?
Pharmacists must adjust their counseling approaches as more treatment options become available for patients with cancer.
Watch
The Demand for Outcomes in the US Drug Market
The biggest spender doesn’t always come out ahead in the world of specialty medications.
Regular Ibuprofen Use May Lower Lung Cancer Risk in Smokers
Individuals with a history of cigarette smoking may benefit from regular ibuprofen use.
Investigational Biotech Diabetes Treatment May Improve Insulin Regulation
Modified kidney cells could potentially regulate insulin for 3 weeks in patients with diabetes.
Can Shorter Courses of Antibiotics Prevent Resistance?
A new study examines a different treatment strategy for pneumonia.
Why Do Some Rheumatoid Arthritis Patients Respond Better to Treatment than Others?
The proportion of specific inflammatory proteins can influence treatment outcomes.
Trending News Today: Cooling Cap May Preserve Hair During Chemotherapy
Top news of the day from across the health care landscape.
Gilead Seeks Approval for Pan-Genotypic Hepatitis C Drug
Once-daily tablet for hepatitis C virus contains sofosbuvir, velpatasvir, and voxilaprevir.
Experimental Drug May Overcome Cancer Treatment Resistance
Checkpoint inhibitor resistance remains an issue in cancer therapy.
Trending News Today: Healthcare Stakeholders Wary of Affordable Care Act Repeal
Top news of the day from across the healthcare landscape.
Smoking Exacerbates Death Risk in HIV
Cigarettes can be a bigger contributor to death in HIV patients than the virus itself.
Lifestyle Changes May Improve Multiple Sclerosis Symptoms
Wellness initiatives may help multiple sclerosis patients better manage symptoms of the disease.
Juvenile Idiopathic Arthritis Drug Shows Promise
Patients with severe refractory juvenile idiopathic arthritis-associated uveitis may achieve complete remission with tocilizumab.
Improved Education Needed for Rheumatoid Arthritis Treatments
Patients with RA may be overwhelmed by information about disease-modifying antirheumatic drugs.
Trump Pledge to Lower Drug Prices Highlights AJPB Week in Review
Top articles of the week on The American Journal of Pharmacy Benefits.
American Society of Hematology Findings Highlight Week in Cancer News
Top news of the week in oncology and cancer drug development.
What Is The Role of the Clinical Pharmacist in the Appeals Process for Oncology Medication Reimbursement?
A Memorial Sloan-Kettering pharmacist discusses the often complicated reimbursement process for oncology medications and appeals.
How Integral To Patient Care Is Collaboration Between Oncology and Pharmacy Teams?
A hematology/oncology clinical pharmacist with Memorial Sloan-Kettering Cancer Center discusses the importance of early collaboration between pharmacists and oncologists in patient care.
Mechanisms Behind Lung Cancer Metastasis Discovered
Inhibiting communication between proteins and the Golgi apparatus could possibly prevent lung cancer metastasis.
What Are the Negative Health Effects of Jet Lag?
Disrupting the body’s circadian clock can increase the risk of serious diseases, such as cancer.
BD Showcases Comprehensive Medication Management Platform
Officials also announced the adoption of Windows 10 Internet of Things (IoT) operating system (OS) for its enterprise-wide Pyxis ES System.
New Initiative Seeks to Improve Treatment for Multiple Myeloma
Myeloma Genome Project to create the largest dataset of molecular profiling for patients with multiple myeloma.
Gilead Submits New Drug Application for Pan-Genotypic Hepatitis C Drug
A once-daily tablet could potentially treat patients with hepatitis c virus genotypes 1 through 6.
Ovarian Cancer Drug Approval Highlights Week in Specialty Pharmacy
Top articles of the week on Specialty Pharmacy Times.
Gazyva Improves Survival in Follicular Lymphoma Patients
In a phase 3 trial, Gazyva showed superior progression-free survival in previously untreated follicular lymphoma.
Breast Cancer Recurrence Points to Cannibalistic Cancer Cells
Research suggests cancer cells may evade treatment by eating adult stem cells.
Gazyva Boosts Outcomes in Follicular Lymphoma
Gazyva is an engineered monoclonal antibody designed to attach to CD20.
Novel Rapid Test Identifies Treatment for Drug-Resistant Bacteria
A rapid test can screen thousands of drugs to determine the best treatment for an antibiotic-resistant bacteria strain.
Trending News Today: Former CEO Charged in Opioid Prescription Kickback Scam